這個(gè)雜志的目的是提供一個(gè)論壇發(fā)表相關(guān)的臨床和實(shí)驗(yàn)藥理學(xué)研究糖尿病、肥胖癥和新陳代謝,包括葡萄糖和weight-lowering新藥評(píng)價(jià)新的治療發(fā)展的管理和預(yù)防糖尿病并發(fā)癥,如生長(zhǎng)因子為足潰瘍和生物技術(shù)產(chǎn)品,涉及建立和臨床試驗(yàn)藥物,如優(yōu)化治療高血壓,糖尿病人群中的脂質(zhì)或感染。

This journal aims to provide a forum for publication of clinical and experimental pharmacology studies related to diabetes, obesity and metabolism, including evaluations of new glucose and weight-lowering drugs, new therapeutic developments in the management and prevention of diabetic complications, e.g. growth factors and biotechnology products for foot ulcers, and clinical trials involving established medicines, e.g. optimal treatment of hypertension, lipids or infection in the diabetic population.